Статья

Combined immunization with attenuated live influenza vaccine and chimeric pneumococcal recombinant protein improves the outcome of virus-bacterial infection in mice

T. Kramskaya, G. Leontieva, Y. Desheva, K. Grabovskaya, T. Gupalova, L. Rudenko, A. Suvorov,
2021

Influenza and its bacterial complications are a leading cause of morbidity and mortality worldwide. The effect of combined immunization with live influenza vaccine and recombinant chimeric pneumococcal protein in dual infection caused by influenza H1N1 and S. pneumoniae (serotype 3) has been studied. The combined vaccine consisted of the strain A/California/2009/38 (H1N1) pdm and chimeric recombinant protein PSPF composed of immunodominant fragments of the surface virulence factors of S. pneumoniae-PsaA, PspA, and Shr1875-associated with modified salmonella flagellin. Vaccinated mice were infected with the influenza virus 24 hours before or 24 hours after the onset of pneumococcal infection. The protective effect of combined vaccination was shown on both models of viralbacterial infection. © 2019 Kramskaya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited

Цитирование

Похожие публикации

Источник

Версии

  • 1. Version of Record от 2021-04-27

Метаданные

Об авторах
  • T. Kramskaya
    Department of Molecular Microbiology, Institute of Experimental Medicine, Saint Petersburg, Russian Federation
  • G. Leontieva
    Department of Virology, Institute of Experimental Medicine, Saint Petersburg, Russian Federation
  • Y. Desheva
    Department of Fundamental Medicine and Medical Technologies, Faculty of Dentistry and Medical Technologies, Saint Petersburg State University, Saint Petersburg, Russian Federation
  • K. Grabovskaya
  • T. Gupalova
  • L. Rudenko
  • A. Suvorov
Название журнала
  • PLoS ONE
Том
  • 14
Выпуск
  • 9
Страницы
  • -
Ключевые слова
  • flagellin; influenza vaccine; PSPF protein; recombinant protein; unclassified drug; virulence factor; bacterial antigen; bacterium antibody; influenza vaccine; live vaccine; Pneumococcus vaccine; recombinant protein; vaccine; animal experiment; animal model; animal tissue; Article; controlled study; female; immunization; immunogenicity; influenza A (H1N1); Influenza A virus (H1N1); Influenza A virus A California 2009 38 H1N1; mixed infection; mouse; nonhuman; pneumococcal infection; Streptococcus pneumoniae; treatment outcome; animal; Bagg albino mouse; disease model; immunology; metabolism; mixed infection; pneumococcal infection; vaccination; Animals; Antibodies, Bacterial; Antigens, Bacterial; Coinfection; Disease Models, Animal; Female; Flagellin; Influenza Vaccines; Mice; Mice, Inbred BALB C; Pneumococcal Infections; Pneumococcal Vaccines; Recombinant Proteins; Treatment Outcome; Vaccination; Vaccines, Attenuated; Vaccines, Combined; Virulence Factors
Издатель
  • Public Library of Science
Тип документа
  • journal article
Тип лицензии Creative Commons
  • CC
Правовой статус документа
  • Свободная лицензия
Источник
  • scopus